Preprint · OA
via OpenAlex
Attenuated Replication-Competent Herpes Simplex Virus Expressing an ECM-Modifying Transgene Hyaluronan Synthase 2 of Naked Mole Rat in Oncolytic Gene Therapy
Jussi Palomäki, Kiira Kalke, Julius Orpana, Lund Liisa, Fanny Frejborg, Henrik Paavilainen, Järveläinen Hannu, Veijo Hukkanen
UTUPub (University of Turku) · 2025
Abstract
Herpes simplex virus (HSV) has proven successful in treating human cancer. Since the approval of talimogene laherparepvec (T-VEC) in 2015, HSV has been thoroughly researched to discover novel mechanisms to combat cancer and treat other diseases. Another HSV-based drug, beremagene geperpavec (B-VEC), received approval in 2023 to treat the rare genetic disease dystrophic epidermolysis bullosa, and was also the first clinically approved HSV vector carrying an extracellular matrix (ECM)-modifying transgene. The ECM is a network of macromolecules surrounding cells, which provides support and regulates cell growth and differentiation, the disruption of which is common in cancer. The naked mole rat (NMR) has a thick ECM and a unique mutation in the hyaluronan synthase 2 (HAS2) gene, which has been linked to the high cancer resistance of the species. To study the effect of this mutation in human cancer, we have developed an attenuated, replication-competent HSV vector expressing the NMR-HAS2 gene. The viral replication, transgene expression and cytotoxic effect of the novel vector was studied in glioma cells. Our results show that an attenuated, replication-competent HSV vector expressing a foreign ECM-modifying transgene, namely HAS2, provides an effective tool to study and combat cancer in humans.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-11-03 MST
Cite this
APA
Palomäki, J., Kalke, K., Orpana, J., Liisa, L., Frejborg, F., Paavilainen, H., Hannu, J., & Hukkanen, V. (2025). Attenuated Replication-Competent Herpes Simplex Virus Expressing an ECM-Modifying Transgene Hyaluronan Synthase 2 of Naked Mole Rat in Oncolytic Gene Therapy. <em>UTUPub (University of Turku)</em>. https://openalex.org/W7137617239
Vancouver
Palomäki J, Kalke K, Orpana J, Liisa L, Frejborg F, Paavilainen H, et al. Attenuated Replication-Competent Herpes Simplex Virus Expressing an ECM-Modifying Transgene Hyaluronan Synthase 2 of Naked Mole Rat in Oncolytic Gene Therapy. UTUPub (University of Turku). 2025.
BibTeX
@unpublished{jussi2025Attenu,
title = {Attenuated Replication-Competent Herpes Simplex Virus Expressing an ECM-Modifying Transgene Hyaluronan Synthase 2 of Naked Mole Rat in Oncolytic Gene Therapy},
author = {Jussi Palomäki and Kiira Kalke and Julius Orpana and Lund Liisa and Fanny Frejborg and Henrik Paavilainen and Järveläinen Hannu and Veijo Hukkanen},
journal = {UTUPub (University of Turku)},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Microorganisms 2023
Open access · CC-BY
Attenuated Replication-Competent Herpes Simplex Virus Expressing an ECM-Modifying Transgene Hyaluronan Synthase 2 of Naked Mole Rat in Oncolytic Gene Therapy
2023
Preprint · CC-BY
Mechanisms of Cancer Resistance Across Mammals
PLoS ONE 2012
Open access · CC-BY
Mesenchymal Stem Cells Repress Th17 Molecular Program through the PD-1 Pathway
Nature 2013
Preprint · OA
High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat
PLoS ONE 2014
Open access · CC-BY
Evolution of Human Longevity Uncoupled from Caloric Restriction Mechanisms
bioRxiv (Cold Spring Harbor Laboratory) 2020
Preprint · CC-BY